Top

Published in:

01-03-2014 | Original Research

Dulce Mothers: an intervention to reduce diabetes and cardiovascular risk in Latinas after gestational diabetes

Authors: Athena Philis-Tsimikas, MD, Addie L. Fortmann, PhD, Sapna Dharkar-Surber, MPH, Johanna A. Euyoque, MA, Monica Ruiz, MA, James Schultz, MD, MBA, Linda C. Gallo, PhD

Published in: Translational Behavioral Medicine | Issue 1/2014

Abstract

Latina women with prior gestational diabetes mellitus (GDM) are at elevated risk for type 2 diabetes mellitus and cardiovascular disease. Few primary prevention programs are designed for low socioeconomic status, Spanish-speaking populations. We examined the effectiveness of a Diabetes Prevention Program (DPP) translation in low-income Latinas with a history of GDM. Eighty-four Latinas, 18–45 years old with GDM in the past 3 years, underwent an 8-week peer-educator-led group intervention, with tailoring for Latino culture and recent motherhood. Lifestyle changes and diabetes and cardiovascular risk factors were assessed at study baseline, month 3 and month 6. Participants showed significant improvements in lipids, blood pressure, physical activity, dietary fat intake, and fatalistic and cultural diabetes beliefs (p < 0.05). Formative evaluation provides preliminary evidence of program acceptability. A peer-led, culturally appropriate DPP translation was effective in improving lifestyle changes and some indicators of cardiovascular and diabetes risk in Latinas with GDM.

Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet. 2009;373(9677):1773-1779.PubMedCrossRef

Di Cianni G, Ghio A, Resi V, Volpe L. Gestational diabetes mellitus: an opportunity to prevent type 2 diabetes and cardiovascular disease in young women. Womens Health. 2010;6(1):97-105.

US Center for Health Statistics. Births: final data for 2008. Natl Vital Stat Rep. 2010;59(1):3-71.

Ferrara A. Increasing prevalence of gestational diabetes mellitus. Diabetes Care. 2007;30(Supplement 2):S141-S146.PubMedCrossRef

Cowie CC, Rust KF, Ford ES, et al. Full accounting of diabetes and pre-diabetes in the US population in 1988–1994 and 2005–2006. Diabetes Care. 2009;32(2):287-294.PubMedCentralPubMedCrossRef

Kjos SL, Peters RK, Xiang A, Henry OA, Montoro M, Buchanan TA. Predicting future diabetes in Latino women with gestational diabetes. Utility of early postpartum glucose tolerance testing. Diabetes. 1995;44(5):586-591.PubMedCrossRef

Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403.PubMedCrossRef

Diabetes Prevention Program Research Group, Knowler WC, Fowler SE, et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program outcomes study. Lancet. 2009;374(9702):1677-1686.PubMedCrossRef

Ratner R, Goldberg R, Haffner S, et al. Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program. Diabetes Care. 2005;28(4):888-894.PubMedCrossRef

10.

The Diabetes Prevention Program Outcomes Study Research Group. Long-term effects of the Diabetes Prevention Program interventions on cardiovascular risk factors: a report from the DPP Outcomes Study. Diabet Med. 2013;30(1):46-55.CrossRef

11.

Jackson L. Translating the diabetes prevention program into practice. Diabetes Educ. 2009;35(2):309-320.PubMedCrossRef

12.

Ali MK, Echouffo-Tcheugui JB, Williamson DF. How effective were lifestyle interventions in real-world settings that were modeled on the Diabetes Prevention Program? Health Aff. 2012;31(1):67-75.CrossRef

13.

Ferrara A, Ehrlich SF. Diabetes prevention interventions for women with a history of GDM. In: Kim C, Ferrara A, eds. Gestational diabetes during and after pregnancy. London: Springer; 2010:361-372.CrossRef

14.

Ferrara A, Hedderson MM, Albright CL, et al. A pregnancy and postpartum lifestyle intervention in women with gestational diabetes mellitus reduces diabetes risk factors: a feasibility randomized control trial. Diabetes Care. 2011;34(7):1519-1525.PubMedCentralPubMedCrossRef

15.

Bentley-Lewis R. Gestational diabetes mellitus: an opportunity of a lifetime. Lancet. 2009;373(9677):1738-1740.PubMedCrossRef

16.

Ratner RE, Christophi CA, Metzger BE, et al. Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions. J Clin Endocrinol Metab. 2008;93(12):4774-4779.PubMedCentralPubMedCrossRef

17.

Ockene IS, Tellez TL, Rosal MC, et al. Outcomes of a Latino community-based intervention for the prevention of diabetes: the Lawrence Latino Diabetes Prevention Project. Am J Public Health. 2012;102(2):336-342.PubMedCentralPubMedCrossRef

18.

Castro FG, Shaibi GQ, Boehm-Smith E. Ecodevelopmental contexts for promoting exercise for preventing diabetes among racial/ethnic minority populations. J Behav Med. 2009;32(1):89-105.PubMedCentralPubMedCrossRef

19.

Caballero AE. Understanding the Hispanic/Latino patient. Am J Med. 2011;124:S10-S15.PubMedCrossRef

20.

Ayala GX, Vaz L, Earp JA, Elder JP, Cherrington A. Outcome effectiveness of the lay health advisor model among Latinos in the United States: an examination by role. Health Educ Res. 2010;25(5):815-840.PubMedCentralPubMedCrossRef

21.

Rhodes SD, Foley KL, Zometa CS, Bloom FR. Lay health advisor interventions among Hispanics/Latinos: a qualitative systematic review. Am J Prev Med. 2007;33(5):418-427.PubMedCrossRef

22.

American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2013;36(Supplement 1):S67-S74.PubMedCentralCrossRef

23.

Bandura A. Health promotion by social cognitive means. Health Educ Behav. 2004;31(2):143-164.PubMedCrossRef

24.

Bandura A. Social learning theory. Englewood Cliffs, NJ: Prentice-Hall; 1977.

25.

Bandura A. Self-efficacy: the exercise of control. New York: Freeman; 1997.

26.

Warnick GR. Measurement of cholesterol and other lipoprotein constituents in the clinical laboratory. Clin Chem Lab Med. 2000;38(4):287-300.PubMedCrossRef

27.

Neeley WE. Simple automated determination of serum or plasma glucose by a hexokinase/glucose-6-phosphate dehydrogenase method. Clin Chem. 1972;18(6):509-515.PubMed

28.

Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289(19):2560-2572.PubMedCrossRef

29.

Block G, Gillespie C, Rosenbaum EH, Jenson C. A rapid food screener to assess fat and fruit and vegetable intake. Am J Prev Med. 2000;18(4):284-288.PubMedCrossRef

30.

Block G, Hartman AM, Dresser CM, Carroll MD, Gannon J, Gardner L. A data-based approach to diet questionnaire design and testing. Am J Epidemiol. 1986;124(3):453-469.PubMed

31.

Elder JP, Ayala GX, Campbell NR, et al. Interpersonal and print nutrition communication for a Spanish-dominant Latino population: secretos de la buena vida. Health Psychol. 2005;24(1):49-57.PubMedCrossRef

32.

Topolski TD, LoGerfo J, Patrick DL, Williams B, Walwick J, Patrick MB. The rapid assessment of physical activity (RAPA) among older adults. Prev Chron Dis. 2006;3(4):A118.

33.

Powe BD. Fatalism among elderly African Americans. Effects on colorectal cancer screening. Cancer Nurs. 1995;18(5):385-392.PubMedCrossRef

34.

Lopez-McKee G, McNeill JA, Eriksen LR, Ortiz M. Spanish translation and cultural adaptation of the Powe Fatalism Inventory. J Nurs Scholarsh. 2007;39(1):68-70.PubMedCrossRef

35.

Philis-Tsimikas A, Walker C, Rivard L, et al. Improvement in diabetes care of underinsured patients enrolled in project dulce: a community-based, culturally appropriate, nurse case management and peer education diabetes care model. Diabetes Care. 2004;27(1):110-115.PubMedCrossRef

36.

Corporation IBM. IBM SPSS Statistics for Windows, Version 20.0. Armonk, NY: IBM Corp.; 2011.

37.

Raudenbush SW, Bryk AS, Congdon R. HLM 6 for Windows. Lincolnwood, IL: Scientific Software International; 2004.

38.

Enders CK. Applied missing data analysis. New York: Guilford; 2010.

39.

Philis-Tsimikas A, Fortmann A, Lleva-Ocana L, Walker C, Gallo LC. Peer-led diabetes education programs in high-risk Mexican Americans improve glycemic control compared with standard approaches: a Project Dulce promotora randomized trial. Diabetes Care. 2011;34(9):1926-1931.PubMedCentralPubMedCrossRef

40.

The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA. 1984; 251(3): 365–374.

41.

Colhoun HM, Betteridge DJ, Durrington PN, et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet. 2004;364(9435):685-696.PubMedCrossRef

42.

Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. JAMA. 1998;279(20):1615-1622.PubMedCrossRef

43.

Estruch R, Ros E, Salas-Salvadó J, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. 2013;368(14):1279-1290.PubMedCrossRef

44.

Investigators HOPES. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. Lancet. 2000;355(9200):253-259.CrossRef

45.

Pedersen TR, Olsson AG, Faergeman O, et al. Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S). Circulation. 1998;97(15):1453-1460.PubMedCrossRef

46.

Cook NR, Cohen J, Hebert PR, Taylor JO, Hennekens CH. Implications of small reductions in diastolic blood pressure for primary prevention. Arch Intern Med. 1995;155(7):701-709.PubMedCrossRef

47.

Diabetes Prevention Program Work Group. Impact of intensive lifestyle and Metformin therapy on cardiovascular disease risk factors in the Diabetes Prevention Program. Diabetes Care. 2005;28(4):888-894.CrossRef

48.

Feathers JT, Kieffer EC, Palmisano G, et al. The development, implementation, and process evaluation of the REACH Detroit Partnership’s diabetes lifestyle intervention. Diabetes Educ. 2007;33(3):509-520.PubMedCrossRef

49.

Rosal M, Lemon S, Nguyen O, Driscoll N, DiTaranto L. Translation of the diabetes prevention program lifestyle intervention for promoting postpartum weight loss among low-income women. Transl Behav Med. 2011;1(4):530-538.PubMedCentralPubMedCrossRef

50.

Cole-Lewis H, Kershaw T. Text messaging as a tool for behavior change in disease prevention and management. Epidemiol Rev. 2010;32(1):56-69.PubMedCentralPubMedCrossRef

51.

Bennett GG, Glasgow RE. The delivery of public health interventions via the Internet: actualizing their potential. Annu Rev Public Health. 2009;30:273-292.PubMedCrossRef

52.

Goode AD, Reeves MM, Eakin EG. Telephone-delivered interventions for physical activity and dietary behavior change: an updated systematic review. Am J Prev Med. 2012;42(1):81-88.PubMedCrossRef

53.

Bennett GG, Warner ET, et al. Obesity treatment for socioeconomically disadvantaged patients in primary care practice. Arch Intern Med. 2012;172(7):565-574.PubMedCentralPubMedCrossRef

54.

Bentley-Lewis R. Late cardiovascular consequences of gestational diabetes mellitus. Semin Reprod Med. 2009;27(4):322-329.PubMedCrossRef

Title: Dulce Mothers: an intervention to reduce diabetes and cardiovascular risk in Latinas after gestational diabetes
Authors: Athena Philis-Tsimikas, MD
Addie L. Fortmann, PhD
Sapna Dharkar-Surber, MPH
Johanna A. Euyoque, MA
Monica Ruiz, MA
James Schultz, MD, MBA
Linda C. Gallo, PhD
Publication date: 01-03-2014
Publisher: Springer US
Published in: Translational Behavioral Medicine / Issue 1/2014
Print ISSN: 1869-6716
Electronic ISSN: 1613-9860
DOI: https://doi.org/10.1007/s13142-014-0253-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Dulce Mothers: an intervention to reduce diabetes and cardiovascular risk in Latinas after gestational diabetes

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2014

Minimal intervention needed for change: definition, use, and value for improving health and health research

Game playbooks: tools to guide multidisciplinary teams in developing videogame-based behavior change interventions

Modeling the sustainability of community health networks: novel approaches for analyzing collaborative organization partnerships across time

Assessing the research use and needs of organizations promoting healthy living for adults with disabilities

Mediators and moderators of behavior change in patients with chronic cardiopulmonary disease: the impact of positive affect and self-affirmation

News from the NIH: improving health and reducing premature mortality in people with serious mental illnesses